Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
University of Washington · Institute for Health Metrics and Evaluation · +4 more institutions
Abstract
Future trends in disease burden and drivers of health are of great interest to policy makers and the public at large. This information can be used for policy and long-term health investment, planning, and prioritisation. We have expanded and improved upon previous forecasts produced as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) and provide a reference forecast (the most likely future), and alternative scenarios assessing disease burden trajectories if selected sets of risk factors were eliminated from current levels by 2050.
Using forecasts of major drivers of health such as the Socio-demographic Index (SDI; a composite measure of lag-distributed income per capita, mean years of education, and total fertility under 25 years of age) and the full set of risk factor exposures captured by GBD, we provide cause-specific forecasts of mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) by age and sex from 2022 to 2050 for 204 countries and territories, 21 GBD regions, seven super-regions, and the world. All analyses were done at the cause-specific level so that only risk factors deemed causal by the GBD comparative risk assessment influenced future trajectories of mortality for each disease. Cause-specific mortality was modelled using mixed-effects models with SDI and time as the main covariates, and the combined impact of causal risk factors as an offset in the model. At the all-cause mortality level, we captured unexplained variation by modelling residuals with an autoregressive integrated moving average model with drift attenuation. These all-cause forecasts constrained the cause-specific forecasts at successively deeper levels of the GBD cause hierarchy using cascading mortality models, thus ensuring a robust estimate of cause-specific mortality. For non-fatal measures (eg, low back pain), incidence and prevalence were forecasted from mixed-effects models with SDI as the main covariate, and YLDs were computed from the resulting prevalence forecasts and average disability weights from GBD. Alternative future scenarios were constructed by replacing appropriate reference trajectories for risk factors with hypothetical trajectories of gradual elimination of risk factor exposure from current levels to 2050. The scenarios were constructed from various sets of risk factors: environmental risks (Safer Environment scenario), risks associated with communicable, maternal, neonatal, and nutritional diseases (CMNNs; Improved Childhood Nutrition and Vaccination scenario), risks associated with major non-communicable diseases (NCDs; Improved Behavioural and Metabolic Risks scenario), and the combined effects of these three scenarios. Using the Shared Socioeconomic Pathways climate scenarios SSP2-4.5 as reference and SSP1-1.9 as an optimistic alternative in the Safer Environment scenario, we accounted for climate change impact on health by using the most recent Intergovernmental Panel on Climate Change temperature forecasts and published trajectories of ambient air pollution for the same two scenarios. Life expectancy and healthy life expectancy were computed using standard methods. The forecasting framework includes computing the age-sex-specific future population for each location and separately for each scenario. 95% uncertainty intervals (UIs) for each individual future estimate were derived from the 2·5th and 97·5th percentiles of distributions generated from propagating 500 draws through the multistage computational pipeline.
Citation impact
- FWCI
- 469.43
- Percentile
- 100%
- References
- 49
Authors
1420- SEStein Emil Vollset
- HAHazim Ababneh
University of Washington, Institute for Health Metrics and Evaluation
- YAYohannes Abate
University of Washington, Institute for Health Metrics and Evaluation
- CACristiana Abbafati
University of Washington, Institute for Health Metrics and Evaluation
- RARouzbeh Abbasgholizadeh
University of Washington, Institute for Health Metrics and Evaluation
Topics & keywords
- Life expectancy
- Disease burden
- Environmental health
- Medicine
- Disability-adjusted life year
- Public health
- Disease
- Demography
Funding
- ADAmerican Diabetes Association
- BABill and Melinda Gates FoundationAward: OPP1152504
- CCConquer Cancer Foundation
- AAmgen
- AAstraZeneca
- SSanofi
- WHWorld Health Organization
- AVAlexander von Humboldt-Stiftung
- GSGilead Sciences
- BBiogen
- APAlexion Pharmaceuticals
- KDKorean Diabetes Association
- SJSt. Jude Children's Research Hospital
- IPInternational Parkinson and Movement Disorder Society
- WTWellcome Trust
- IAInternational Association for Suicide Prevention
- BPBloomberg Philanthropies
- ATAmicus Therapeutics
- FMFresenius Medical Care North America
- MCMinisterul Cercetării, Inovării şi DigitalizăriiAward: ID-585-CTR-42-PFE-2021
- NINational Institute of Mental Health and Neurosciences
- NINational Institute for Health and Care Research
- UOUniversity of Oxford
- ECEuropean CommissionAward: 848325
- NRNational Research Foundation
- DODepartment of Biotechnology, Ministry of Science and Technology, India
- DODepartment of Science and Technology, Ministry of Science and Technology, India
- ICIndian Council of Medical Research
- DFDeutsche Forschungsgemeinschaft
- BFBundesministerium für Bildung und Forschung
- MOMinistry of Education
- MOMinistry of Trade, Industry and EnergyAward: P0017805
- CNConselho Nacional de Desenvolvimento Científico e TecnológicoAwards: UIDP/50006/2020, 304224/2022-7
- KIKorea Institute for Advancement of TechnologyAward: P0017805
- NRNational Research Foundation of KoreaAwards: NRF-2023S1A3A2A05095298, 2020H1D3A1A04081265
- HHjärt-Lungfonden
- NNNovo Nordisk
- APAstellas Pharma
- UNUniversidade Nova de Lisboa
- MDMinistério da Ciência, Tecnologia e Ensino SuperiorAwards: LA/P/0140/2020, UIDB/04378/2020, UIDP/04378/2020, 10.54499/UIDP/50006/2020, UIDP/50006/2020
- UDUniversidade do Porto
- SLSvenska Läkaresällskapet
- TWThe Wellcome Trust DBT India Alliance
- FBFondation Botnar
- HLH. Lundbeck A/S
- MOMinistry of Science and ICT, South KoreaAward: 2020H1D3A1A04081265
- AMApplied Molecular Biosciences UnitAwards: LA/P/0140/2020, UIDP/50006/2020, UIDP/04378/2020, UIDB/04378/2020
- IPIdorsia Pharmaceuticals
- RDRede de Química e TecnologiaAward: UIDP/50006/2020
- LALaboratório Associado para a Química VerdeAwards: 10.54499/UIDP/50006/2020, UIDP/50006/2020, UIDP/04378/2020, UIDB/04378/2020
- NINational Institutes of Health
- CICanadian Institutes of Health Research
- MRMedical Research Council
- WCWorld Cancer Research Fund
- JSJapan Society for the Promotion of ScienceAwards: 2023-2025, 175042, 50006
- SAScience and Engineering Research Board
- FPFundação para a Ciência e a TecnologiaAwards: UIDP/50006/2020, UIDB/04378/2020, UIDP/04378/2020, LA/P/0140/2020, 10.54499/UIDP/50006/2020
- BIBiotechnology Industry Research Assistance Council
- NINational Institute of Mental Health